Gainers
- INmune Bio INMB shares moved upwards by 18.76% to $28.35 during Wednesday's after-market session. Trading volume for this security closed at 588.2K, accounting for 131.25% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $501.8 million.
- Recro Pharma REPH stock increased by 7.28% to $2.65. The market value of their outstanding shares is at $123.2 million.
- Avalon Globocare AVCO shares moved upwards by 5.72% to $1.09. The market value of their outstanding shares is at $93.0 million.
- Axcella Health AXLA stock increased by 4.3% to $3.68. The market value of their outstanding shares is at $140.5 million.
- Oyster Point Pharma OYST shares increased by 3.42% to $13.9. The company's market cap stands at $361.6 million.
- 180 Life Sciences ATNF shares increased by 2.87% to $6.8. The market value of their outstanding shares is at $229.6 million.
Losers
- Assembly Biosciences ASMB shares fell 14.11% to $3.35 during Wednesday's after-market session. Today's trading volume for this security ended up closing at 244.8K shares, which is 20.58 percent of its average volume over the last 100 days. The company's market cap stands at $150.6 million.
- Veeva Systems VEEV stock fell 10.04% to $300.61. Today's trading volume for this security ended up closing at 162.6K shares, which is 25.67 percent of its average volume over the last 100 days. The market value of their outstanding shares is at $45.9 billion. As per the press release, Q2 earnings came out today.
- Hoth Therapeutics HOTH shares declined by 4.55% to $1.26. The company's market cap stands at $30.0 million.
- Redhill Biopharma RDHL shares fell 3.0% to $10.05. The company's market cap stands at $469.5 million. The company's, Q2 earnings came out 4 days ago.
- Cerevel Therapeutics Hldg CERE shares declined by 2.59% to $32.8. The company's market cap stands at $4.7 billion.
- NeuroMetrix NURO stock decreased by 2.44% to $11.61. The company's market cap stands at $65.3 million.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in